Free Trial
NASDAQ:BLFS

BioLife Solutions (BLFS) Stock Price, News & Analysis

BioLife Solutions logo
$26.59 +0.68 (+2.62%)
Closing price 04:00 PM Eastern
Extended Trading
$26.59 0.00 (0.00%)
As of 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About BioLife Solutions Stock (NASDAQ:BLFS)

Advanced

Key Stats

Today's Range
$26.17
$27.42
50-Day Range
$20.64
$26.74
52-Week Range
$19.10
$29.55
Volume
372,572 shs
Average Volume
366,176 shs
Market Capitalization
$1.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.29
Consensus Rating
Moderate Buy

Company Overview

BioLife Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

BLFS MarketRank™: 

BioLife Solutions scored higher than 51% of companies evaluated by MarketBeat, and ranked 584th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BioLife Solutions has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 7 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    BioLife Solutions has a consensus price target of $31.29, representing about 17.7% upside from its current price of $26.59.

  • Amount of Analyst Coverage

    BioLife Solutions has only been the subject of 4 research reports in the past 90 days.

  • Read more about BioLife Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for BioLife Solutions are expected to grow in the coming year, from ($0.30) to ($0.13) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BioLife Solutions is -221.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BioLife Solutions is -221.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BioLife Solutions has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about BioLife Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    8.20% of the outstanding shares of BioLife Solutions have been sold short.
  • Short Interest Ratio / Days to Cover

    BioLife Solutions has a short interest ratio ("days to cover") of 7.9.
  • Change versus previous month

    Short interest in BioLife Solutions has recently decreased by 0.25%, indicating that investor sentiment is improving.
  • Dividend Yield

    BioLife Solutions does not currently pay a dividend.

  • Dividend Growth

    BioLife Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.20% of the outstanding shares of BioLife Solutions have been sold short.
  • Short Interest Ratio / Days to Cover

    BioLife Solutions has a short interest ratio ("days to cover") of 7.9.
  • Change versus previous month

    Short interest in BioLife Solutions has recently decreased by 0.25%, indicating that investor sentiment is improving.
  • News Sentiment

    BioLife Solutions has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for BioLife Solutions this week, compared to 5 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,981,317.00 in company stock.

  • Percentage Held by Insiders

    Only 2.20% of the stock of BioLife Solutions is held by insiders.

  • Percentage Held by Institutions

    93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BioLife Solutions' insider trading history.
Receive BLFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BLFS Stock News Headlines

U.S. Government Sparking Crypto Rally
U.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised to benefit from this massive shift inside my Bull Run Millionaire Blueprint.tc pixel
BioLife: Back To Basics Is Getting Traction (Rating Upgrade)
See More Headlines

BLFS Stock Analysis - Frequently Asked Questions

BioLife Solutions' stock was trading at $25.96 on January 1st, 2025. Since then, BLFS stock has increased by 2.4% and is now trading at $26.59.

BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings data on Thursday, August, 7th. The medical equipment provider reported ($0.33) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.31. The medical equipment provider had revenue of $25.42 million for the quarter, compared to analysts' expectations of $23.71 million. BioLife Solutions had a negative net margin of 5.39% and a positive trailing twelve-month return on equity of 0.16%.
Read the conference call transcript
.

Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
8/07/2025
Today
10/03/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BLFS
CIK
834365
Employees
440
Year Founded
1987

Price Target and Rating

High Price Target
$33.00
Low Price Target
$30.00
Potential Upside/Downside
+17.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.18 million
Net Margins
-5.39%
Pretax Margin
-18.34%
Return on Equity
0.16%
Return on Assets
0.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.43
Quick Ratio
3.45

Sales & Book Value

Annual Sales
$82.25 million
Price / Sales
15.49
Cash Flow
$0.13 per share
Price / Cash Flow
211.49
Book Value
$7.52 per share
Price / Book
3.54

Miscellaneous

Outstanding Shares
47,900,000
Free Float
46,851,000
Market Cap
$1.27 billion
Optionable
Optionable
Beta
1.95

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:BLFS) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners